HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS PDE 4 INHIBITORS
申请人:Merck Frosst Canada & Co.
公开号:EP1180100A2
公开(公告)日:2002-02-20
US6180650B1
申请人:——
公开号:US6180650B1
公开(公告)日:2001-01-30
[EN] HETEROSUBSTITUTED PYRIDINE DERIVATIVES AS PDE 4 INHIBITORS<br/>[FR] DERIVES DE PYRIDINE HETEROSUBSTITUES INHIBITEURS DE PDE 4
申请人:MERCK FROSST CANADA INC
公开号:WO2000064874A2
公开(公告)日:2000-11-02
The invention encompasses the novel compound of Formula (I) useful in the treatment of diseases, including asthma, by raising the level of cyclic adenosine-3',5'-monophosphate (cAMP) through the inhibition of phosphodiesterase IV (PDE 4). The invention also encompasses pharmaceutical compositions and methods for treatment.